Literature DB >> 22042084

Replication of Crohn's disease-associated AIEC within macrophages is dependent on TNF-α secretion.

Marie-Agnès Bringer1, Elisabeth Billard, Anne-Lise Glasser, Jean-Frédéric Colombel, Arlette Darfeuille-Michaud.   

Abstract

Adherent and invasive Escherichia coli (AIEC) associated with Crohn's disease are able to survive and to replicate extensively in active phagolysosomes within macrophages. AIEC-infected macrophages release large amounts of tumour necrosis factor-alpha (TNF-α) and do not undergo cell death. The aim of the present study was to determine what benefit AIEC bacteria could gain from inducing the release of large amounts of TNF-α by infected macrophages and to what extent the neutralization of TNF-α could affect AIEC intramacrophagic replication. Our results showed that the amount of TNF-α released by infected macrophages is correlated with the load of intramacrophagic AIEC bacteria and their intracellular replication. TNF-α secretion was not related to the number of bacteria entering host cells because when the number of bacteria internalized in macrophage was decreased by blocking lipid raft-dependent and clathrin-coated pits-dependent endocytosis, the amount of TNF-α secreted by infected macrophages was not modified. Interestingly, dose-dependent increases in the number of intracellular AIEC LF82 bacteria were observed when infected macrophages were stimulated with exogenous TNF-α, and neutralization of TNF-α secreted by AIEC-infected macrophages using anti-TNF-α antibodies induced a significant decrease in the number of intramacrophagic bacteria. These results indicate that AIEC bacteria use TNF-α as a Trojan horse to ensure their intracellular replication because replication of AIEC bacteria within macrophages induces the release of TNF-α, which in turn increases the intramacrophagic replication of AIEC. Neutralizing TNF-α secreted by infected macrophages may represent an effective strategy to control AIEC intracellular replication.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22042084     DOI: 10.1038/labinvest.2011.156

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  21 in total

Review 1.  Impact of the gut microbiome on mucosal inflammation.

Authors:  Warren Strober
Journal:  Trends Immunol       Date:  2013-08-16       Impact factor: 16.687

Review 2.  New targets for mucosal healing and therapy in inflammatory bowel diseases.

Authors:  M F Neurath
Journal:  Mucosal Immunol       Date:  2013-10-02       Impact factor: 7.313

3.  Subversion of human intestinal mucosa innate immunity by a Crohn's disease-associated E. coli.

Authors:  A Jarry; L Crémet; N Caroff; C Bou-Hanna; J M Mussini; A Reynaud; A L Servin; J F Mosnier; V Liévin-Le Moal; C L Laboisse
Journal:  Mucosal Immunol       Date:  2014-10-01       Impact factor: 7.313

4.  Professor Arlette Darfeuille-Michaud: the discovery of adherent-invasive Escherichia coli.

Authors:  Ye Yang; Christian Jobin
Journal:  J Crohns Colitis       Date:  2015-03-10       Impact factor: 9.071

Review 5.  Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Authors:  Georgina L Hold; Megan Smith; Charlie Grange; Euan Robert Watt; Emad M El-Omar; Indrani Mukhopadhya
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

Review 6.  Infectious etiopathogenesis of Crohn's disease.

Authors:  Jessica Carrière; Arlette Darfeuille-Michaud; Hang Thi Thu Nguyen
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 7.  Host-microbe interactions in the small bowel.

Authors:  Julie M Davies; Maria T Abreu
Journal:  Curr Opin Gastroenterol       Date:  2015-03       Impact factor: 3.287

8.  Chitin-binding domains of Escherichia coli ChiA mediate interactions with intestinal epithelial cells in mice with colitis.

Authors:  Daren Low; Hoa T Tran; In-Ah Lee; Nicolas Dreux; Alan Kamba; Hans-Christian Reinecker; Arlette Darfeuille-Michaud; Nicolas Barnich; Emiko Mizoguchi
Journal:  Gastroenterology       Date:  2013-05-16       Impact factor: 22.682

9.  Crohn's disease-associated Escherichia coli survive in macrophages by suppressing NFκB signaling.

Authors:  Khalidur Rahman; Maiko Sasaki; Asma Nusrat; Jan-Michael A Klapproth
Journal:  Inflamm Bowel Dis       Date:  2014-08       Impact factor: 5.325

Review 10.  Fusobacterium and Enterobacteriaceae: important players for CRC?

Authors:  Emma Allen-Vercoe; Christian Jobin
Journal:  Immunol Lett       Date:  2014-06-24       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.